Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001692:Biological Transport; D000013:Congenital Abnormalities / Q000209:etiology; D003920:Diabetes Mellitus / Q000209:etiology* / Q000235:genetics / Q000378:metabolism; D003956:Dialysis; D003964:Diaphragm / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D006003:Glycogen / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000235:genetics / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D007329:Insulin Antagonists; D007330:Insulin Antibodies; D009132:Muscles / Q000378:metabolism; D009765:Obesity; D010455:Peptides / Q000378:metabolism; D011236:Prediabetic State / Q000378:metabolism; D011247:Pregnancy; D011254:Pregnancy in Diabetics; D012709:Serum Albumin / Q000502:physiology
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007329:Insulin Antagonists; D007330:Insulin Antibodies; D010455:Peptides; D012709:Serum Albumin; D013006:Growth Hormone; D006003:Glycogen; D005947:Glucose